Pendal Group’s Chemed CHE Stock Holding History

Pendal Group’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-685	Closed	-$319K	–	561
2021 Q3	$319K	Buy	+685	New	+$323K	﹤0.01%	481
2020 Q2	–	Sell	-298	Closed	-$129K	–	440
2020 Q1	$129K	Buy	298 +100	+51%	+$44.7K	﹤0.01%	364
2019 Q4	$87K	Buy	+198	New	+$83.3K	﹤0.01%	408

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Pendal Group's CHE Position: Q4 2021 in Review

Pendal Group sold out of Chemed (CHE) in Q4 2021, closing a stake of 685 shares — an estimated $319K sold.

Pendal Group first reported a position in CHE in Q4 2019 and held it in 3 quarters. The position peaked at $319K in Q3 2021. 420 funds tracked by Wall St. Rank hold CHE as of Q4 2021.

Pendal Group reported no remaining Chemed position as of Q4 2021 after selling out during the quarter.
Pendal Group sold 685 Chemed shares in Q4 2021, an estimated $319K.
Pendal Group first reported a position in Chemed in Q4 2019 and held it in 3 quarters.
Pendal Group's Chemed position peaked at $319K in Q3 2021.
420 funds tracked by Wall St. Rank held Chemed as of Q4 2021.

Based on Pendal Group's 13F filing for Q4 2021, filed 18 Jan 2022.